A Retrospective Non Interventional Study on First Line Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)

Clinical trial NCT04317599 · COMPLETED

Trial details

NCT number: NCT04317599
Sponsor: Pierre Fabre Medicament
Status: COMPLETED
Study type: OBSERVATIONAL

BRAF V600E Mutation Positive Metastatic Colorectal Cancer

Start date: 2020-04-12
Primary completion: 2021-03-04
Enrollment: 274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.